article_snippet.sent: The respected medical journal says Avastin is just as effective at tackling wet age-related macular degeneration (AMD) as the current treatment, Lucentis.
article_snippet.sent: Avastin is much cheaper and Avastin is estimated that widespread use of the drug would save the NHS around £102million a year.
article_snippet.sent: Findings from clinical trials suggest Avastin is safe and effective in treating AMD –
article_snippet.sent: but Avastin costs £70 per treatment compared with £740 for an injection of Lucentis.
highlights_snippet.sent: Avastin is effective at tackling wet age-related macular degeneration .
  
highlights_snippet.sent: Cheaper than the current treatment Avastin would save NHS £102million a year .